Uveitis Treatment Market Growth: Drivers Behind Rising Adoption
The Uveitis Treatment Market is witnessing strong growth due to rising autoimmune disorders, improved diagnostic tools, and better patient awareness. Traditional corticosteroids are still used, but biologics and biosimilars are gaining ground for chronic cases. The Uveitis Treatment Market growth is supported by global campaigns to prevent vision impairment.
Patient-centered care, AI diagnostics, and telemedicine platforms are expanding access. However, high costs remain a barrier in underdeveloped economies. Biosimilars are expected to boost affordability and adoption across diverse regions.
FAQQ1: What drives growth?A1: Autoimmune diseases, biologics, and early detection.Q2: What limits growth?A2: High drug costs and limited access in poorer regions.